Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. TNGX
TNGX logo

TNGX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TNGX News

RTW Investments Increases Stake in Tango Therapeutics

23h agoNASDAQ.COM

RTW Investments Acquires 11.8 Million Shares of Tango Therapeutics

1d agoFool

Boxer Capital Acquires $17.55 Million Stake in Corvus Pharmaceuticals

May 17 2026Yahoo Finance

Tango Therapeutics Stock Recovery Opportunity Amid Analyst Upgrades

May 15 2026stocktwits

Tango Therapeutics Q1 Earnings Miss Expectations

May 13 2026seekingalpha

Tango Therapeutics Grants Stock Options and RSUs to Executives

May 04 2026Newsfilter

Tango Therapeutics Appoints New CFO and Executives to Accelerate Growth

Apr 15 2026Newsfilter

Revolution's Cancer Drug Shows Promising Results in Trials

Apr 13 2026stocktwits

Tango Therapeutics Executive Exercises Stock Options

Apr 08 2026Fool

Canaccord Genuity Initiates Coverage of Tango Therapeutics with Buy Rating

Apr 02 2026seekingalpha

Analysis of Insider Stock Transaction at Tango Therapeutics

Mar 30 2026Fool

Tango Therapeutics Executive Sells Shares Amid Stock Surge

Mar 30 2026NASDAQ.COM

B. Riley Increases Target Price for TANGO THERAPEUTICS INC to $21, Up from $14

Mar 27 2026moomoo

Biotech Investment Revives as Institutional Capital Flows Back

Mar 19 2026Globenewswire

Wall Street Analysts Adjust MU Stock Ratings

Mar 09 2026Benzinga

Tango Therapeutics Grants Stock Options and RSUs to New Employee

Mar 06 2026Newsfilter